Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Summary:
- A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
| MarketCap | 2B |
|---|---|
| PE Ratio | |
| PEG Ratio | 0.5 |
| P/B | 18.1 |
| P/S (ttm) | 1.2 |
| Earning Growth (QoQ) | |
| Revenue Growth (QoQ) | |
| Short % | 7% |
| Held by Institutions % | 100% |
| 1 Day Vol Adjusted Return | 0.3 |
| 1 Month Vol Adjusted Return | 4.6 |
| 3 Month Vol Adjusted Return | 15.3 |
| 6 Month Vol Adjusted Return | 29.2 |
| 20 Days SMA Price ZScore | 0.9 |
| 50 Days SMA Price ZScore | 1.6 |
| 12 -26 Days PPO | 5.1 |
| 1 Month Average Short Volume Ratio | 44.4 |
| 1 Day Volume Change ZScore | -0.3 |
| 1 Month Daily Vol | 5.8 |
Stock news
BRENTWOOD, Tenn., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2020 results before the market opens on Wednesday, March 10, 2021, to be followed by a conference call at 8:30 a.m. (Eastern Time) You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Repla...
The big shareholder groups in Surgery Partners, Inc. ( NASDAQ:SGRY ) have power over the company. Insiders often own a...
BRENTWOOD, Tenn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its previously announced underwritten public offering of 7,500,000 shares of its common stock at a public offering price of $30.25 per share. Gross proceeds to Surgery Partners from the offering are expected to be approximately $226.9 million, before deducting underwriting discounts and commissions and other offering expenses payable by Surgery Partners. I...
BRENTWOOD, Tenn., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares to be sold in the offering are to be sold by Surgery Partners. In connection with the offering, Surgery Partners intends to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock. The offering is subject to ma...
In this article, we presented the 10 best mid-cap stocks to buy according to billionaire Brian Higgins. Click to skip ahead and see the 5 Best Mid-Cap Stocks To Buy Billionaire Brian Higgins. Billionaire Brian Higgins, 55, is the co-founder of investment management firm King Street Capital Management. The New York-based firm is managing $17 […]
BRENTWOOD, Tenn., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (the “Company”) will be meeting with investors as part of the 2021 J.P. Morgan Healthcare Conference the week of January 11th, 2021, including a presentation on Monday, January 11, 2021 at 2:50 p.m. (Eastern Time). Based on results through November 2020, the Company is now providing full year 2020 revenue guidance of approximately $1.86 billion and reaffirming its previous full-year 2020 Adjusted ...